Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Subscribe
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
Contact Us
EMJ Gold
Subscribe
FREE
Hepatology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Diagnosis of progressive familial intrahepatic cholestasis in adulthood
6
Mins
September 2024
Progressive familial intrahepatic cholestasis (PFIC) is a cholestatic condition that typically arises in childhood. As such, if an adult…
Read more
10
Mins
4th August 2022
Holistic Patient Care in Primary Biliary Cholangitis
PBC is an immune-mediated, chronic, progressive liver disease characterised by gradual destruction of intrahepatic bile ducts.
9
Mins
4th August 2022
Paediatric Acute-on-Chronic Liver Failure
There is growing recognition of acute-on-chronic liver failure (ACLF) as a distinct clinical syndrome that portends excessively high…
10
Mins
4th August 2022
Non-alcoholic Steatohepatitis: Global Impact and Clinical Consequences
Non-alcoholic steatohepatitis (NASH) is the potentially progressive form of non-alcoholic fatty liver disease (NAFLD). NAFLD and NASH are very common in most regions of the world and are on trajectory to become the most common liver disease at a global scale. Risk for high prevalence and progressiveness include visceral obesity and Type 2 diabetes.
4
Mins
4th August 2022
Post-traumatic Isolated Right Hepatic Duct Injury: A Case Report
A 73-year-old female presented with a rare presentation of extrahepatic ductal injuries post-trauma in the form of a right hepatic duct injury. Such injuries go undetected despite normally advised imaging, presenting a few to several days post-trauma.
11
Mins
26th April 2022
The Impact of Paediatric Cholestatic Liver Disease: Diagnosis, Management, and Treatment Considerations
Cholestatic liver diseases are the leading indications for paediatric liver transplant, and result in significant morbidity and mortality.
6
Mins
11th April 2022
Interview: Charlotte Scott
I have always been curious, wanting to understand how and why everything works. My interest in biology began in secondary school in Ireland, where I had a very energetic teacher, Mr Whisker.
4
Mins
11th April 2022
Interview: Virginia Hernández-Gea
I guess it was a combination of different things. Firstly, hepatology is a very wide specialty that combines internal medicine with interventional procedures, and I liked that very much; secondly, I had an excellent group of medical school teachers who instilled in me their passion for the liver and encouraged me to choose the specialty.
5
Mins
14th March 2022
Sclerosing Cholangitis in a Paediatric Patient
PSC in paediatrics has an insidious course, mild symptoms, and most cases initially present without complications.
Loading posts...
« Previous
1
2
3
4
5
…
17
Next »